Abstract
Pseudomonas aeruginosa is a versatile opportunistic bacterium reasons for hospital-acquired infections specifically to the patients suffering from cystic fibrosis, burns, wounds and also immunocompromised individuals. Diverse resistance mechanisms possessed by the bacterium make them to overcome the effect of various antimicrobial agents. P. aeruginosa possess a plenty of virulence determinants, specifically biofilm, and triggers resistance, which is controlled by cellular communication pathway called quorum sensing (QS). A deep understanding about the pathogenic determinants such as virulence factor and biofilm, and also the interaction with the host, makes the development of therapeutic approaches easier. This chapter gives an insight into the synthesis, structure, function and inhibitors of virulence phenotypes of Pseudomonas aeruginosa.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahire JJ, Hattingh M, Neveling DP, Dicks LM (2016) Copper-containing anti-biofilm nanofiber scaffolds as a wound dressing material. PLoS One 11(3):e0152755
Aiello D, Williams JD, Majgier-Baranowska H, Patel I, Peet NP, Huang J, Lory S, Bowlin TL, Moir DT (2010) Discovery and characterization of inhibitors of Pseudomonas aeruginosa type III secretion. Antimicrob Agents Chemother 54(5):1988–1999
Allesen-Holm M, Barken KB, Yang L, Klausen M, Webb JS, Kjelleberg S, Molin S, Givskov M, Tolker-Nielsen T (2006) A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms. Mol Microbiol 59(4):1114–1128
Al-Shabib NA, Husain FM, Ahmed F, Khan RA, Ahmad I, Alsharaeh E, Khan MS, Hussain A, Rehman MT, Yusuf M, Hassan I (2016) Biogenic synthesis of Zinc oxide nanostructures from Nigella sativa seed: prospective role as food packaging material inhibiting broad-spectrum quorum sensing and biofilm. Sci Rep 6(1):36761
Amin SA, Green DH, Küpper FC, Carrano CJ (2009) Vibrioferrin, an unusual marine siderophore: iron binding, photochemistry, and biological implications. Inorg Chem 48(23):11451–11458
Arya G, Kumari RM, Sharma N, Chatterjee S, Gupta N, Kumar A, Nimesh S (2018) Evaluation of antibiofilm and catalytic activity of biogenic silver nanoparticles synthesized from Acacia nilotica leaf extract. Adv Nat Sci Nanosci Nanotechnol 9(4):045003
Azam MW, Khan AU (2019) Updates on the pathogenicity status of Pseudomonas aeruginosa. Drug Discov Today 24(1):350–359
Balducci E, Papi F, Capialbi DE, Del Bino L (2023) Polysaccharides’ structures and functions in biofilm architecture of antimicrobial-resistant (AMR) pathogens. Int J Mol Sci 24(4):4030
Bijtenhoorn P, Mayerhofer H, Müller-Dieckmann J, Utpatel C, Schipper C, Hornung C, Szesny M, Grond S, Thürmer A, Brzuszkiewicz E, Daniel R (2011) A novel metagenomic short-chain dehydrogenase/reductase attenuates Pseudomonas aeruginosa biofilm formation and virulence on Caenorhabditis elegans. PLoS One 6(10):e26278
Billings N, Ramirez Millan M, Caldara M, Rusconi R, Tarasova Y, Stocker R, Ribbeck K (2013) The extracellular matrix component Psl provides fast-acting antibiotic defense in Pseudomonas aeruginosa biofilms. PLoS Pathog 9(8):e1003526
Bleves S, Viarre V, Salacha R, Michel GP, Filloux A, Voulhoux R (2010) Protein secretion systems in Pseudomonas aeruginosa: a wealth of pathogenic weapons. Int J Med Microbiol 300(8):534–543
Botelho J, Grosso F, Peixe L (2019) Antibiotic resistance in Pseudomonas aeruginosa—mechanisms, epidemiology and evolution. Drug Resist Updat 44:100640
Bouteiller M, Dupont C, Bourigault Y, Latour X, Barbey C, Konto-Ghiorghi Y, Merieau A (2021) Pseudomonas flagella: generalities and specificities. Int J Mol Sci 22(7):3337
Braud A, Hoegy F, Jezequel K, Lebeau T, Schalk IJ (2009) New insights into the metal specificity of the Pseudomonas aeruginosa pyoverdine–iron uptake pathway. Environ Microbiol 11(5):1079–1091
Burrows LL (2012) Pseudomonas aeruginosa twitching motility: type IV pili in action. Annu Rev Microbiol 66:493–520
Byrd MS, Sadovskaya I, Vinogradov E, Lu H, Sprinkle AB, Richardson SH, Ma L, Ralston B, Parsek MR, Anderson EM, Lam JS (2009) Genetic and biochemical analyses of the Pseudomonas aeruginosa Psl exopolysaccharide reveal overlap** roles for polysaccharide synthesis enzymes in Psl and LPS production. Mol Microbiol 73(4):622–638
Camberlein V, Jézéquel G, Haupenthal J, Hirsch AK (2022) The structures and binding modes of small-molecule inhibitors of Pseudomonas aeruginosa elastase LasB. Antibiotics 11(8):1060
Chadha J, Harjai K, Chhibber S (2022) Repurposing phytochemicals as anti-virulent agents to attenuate quorum sensing-regulated virulence factors and biofilm formation in Pseudomonas aeruginosa. Microb Biotechnol 15(6):1695–1718
Chegini Z, Khoshbayan A, Taati Moghadam M, Farahani I, Jazireian P, Shariati A (2020) Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review. Ann Clin Microbiol Antimicrob 19:1–17
Chung J, Eisha S, Park S, Morris AJ, Martin I (2023) How three self-secreted biofilm exopolysaccharides of Pseudomonas aeruginosa, Psl, Pel, and alginate, can each be exploited for antibiotic adjuvant effects in cystic fibrosis lung infection. Int J Mol Sci 24(10):8709
Ciofu O, Tolker-Nielsen T (2019) Tolerance and resistance of Pseudomonas aeruginosa biofilms to antimicrobial agents—how P. aeruginosa can escape antibiotics. Front Microbiol 10:913
Colvin KM, Irie Y, Tart CS, Urbano R, Whitney JC, Ryder C, Howell PL, Wozniak DJ, Parsek MR (2012) The Pel and Psl polysaccharides provide Pseudomonas aeruginosa structural redundancy within the biofilm matrix. Environ Microbiol 14(8):1913–1928
Cornelis P, Dingemans J (2013) Pseudomonas aeruginosa adapts its iron uptake strategies in function of the type of infections. Front Cell Infect Microbiol 3:75
Daboor SM, Raudonis R, Cohen A, Rohde JR, Cheng Z (2019) Marine bacteria, a source for alginolytic enzyme to disrupt Pseudomonas aeruginosa biofilms. Mar Drugs 17(5):307
Darabpour E, Kashef N, Mashayekhan S (2016) Chitosan nanoparticles enhance the efficiency of methylene blue-mediated antimicrobial photodynamic inactivation of bacterial biofilms: an in vitro study. Photodiagn Photodyn Ther 14:211–217
Dasgupta N, Wolfgang MC, Goodman AL, Arora SK, Jyot J, Lory S, Ramphal R (2003) A four-tiered transcriptional regulatory circuit controls flagellar biogenesis in Pseudomonas aeruginosa. Mol Microbiol 50(3):809–824
Dasgupta N, Arora SK, Ramphal R (2004) The flagellar system of Pseudomonas aeruginosa. In: Ramos JL (ed) Pseudomonas. Springer, Boston, MA, pp 675–698
Dean SN, Bishop BM, Van Hoek ML (2011) Susceptibility of Pseudomonas aeruginosa biofilm to alpha-helical peptides: D-enantiomer of LL-37. Front Microbiol 2:128
del Mar Cendra M, Torrents E (2021) Pseudomonas aeruginosa biofilms and their partners in crime. Biotechnol Adv 49:107734
Dragoš A, Kovács ÁT (2017) The peculiar functions of the bacterial extracellular matrix. Trends Microbiol 25(4):257–266
Fazli M, Almblad H, Rybtke ML, Givskov M, Eberl L, Tolker-Nielsen T (2014) Regulation of biofilm formation in Pseudomonas and Burkholderia species. Environ Microbiol 16(7):1961–1981
Filloux A (2011) Protein secretion systems in Pseudomonas aeruginosa: an essay on diversity, evolution, and function. Front Microbiol 2:155
Franklin MJ, Nivens DE, Weadge JT, Howell PL (2011) Biosynthesis of the Pseudomonas aeruginosa extracellular polysaccharides, alginate, Pel, and Psl. Front Microbiol 2:167
Galdino ACM, Branquinha MH, Santos ALS, Viganor L (2017) Pseudomonas aeruginosa and its arsenal of proteases: weapons to battle the host. In: Chakraborti S, Dhalla N (eds) Pathophysiological aspects of proteases. Springer, Singapore, pp 381–397
Garcia-Clemente M, de la Rosa D, Máiz L, Girón R, Blanco M, Olveira C, Canton R, Martinez-García MA (2020) Impact of Pseudomonas aeruginosa infection on patients with chronic inflammatory airway diseases. J Clin Med 9(12):3800
Ghafoor A, Hay ID, Rehm BH (2011) Role of exopolysaccharides in Pseudomonas aeruginosa biofilm formation and architecture. Appl Environ Microbiol 77(15):5238–5246
Gheorghita AA, Li YE, Kitova EN, Bui DT, Pfoh R, Low KE, Whitfield GB, Walvoort MT, Zhang Q, Codée JD, Klassen JS (2022) Structure of the AlgKX modification and secretion complex required for alginate production and biofilm attachment in Pseudomonas aeruginosa. Nat Commun 13(1):7631
Ghosh S, Saha I, Dey A, Lahiri D, Nag M, Sarkar T, Pati S, Rebezov M, Shariati MA, Thiruvengadam M, Ray RR (2022) Natural compounds underpinning the genetic regulation of biofilm formation: an overview. S Afr J Bot 151:92–106
Guillon A, Fouquenet D, Morello E, Henry C, Georgeault S, Si-Tahar M, Hervé V (2018) Treatment of Pseudomonas aeruginosa biofilm present in endotracheal tubes by poly-L-lysine. Antimicrob Agents Chemother 62(11):10–1128
Guo M, Feng C, Ren J, Zhuang X, Zhang Y, Zhu Y, Dong K, He P, Guo X, Qin J (2017) A novel antimicrobial endolysin, LysPA26, against Pseudomonas aeruginosa. Front Microbiol 8:293
Harmsen M, Yang L, Pamp SJ, Tolker-Nielsen T (2010) An update on Pseudomonas aeruginosa biofilm formation, tolerance, and dispersal. FEMS Immunol Med Microbiol 59(3):253–268
Häußler S (2004) Biofilm formation by the small colony variant phenotype of Pseudomonas aeruginosa. Environ Microbiol 6(6):546–551
Hoge R, Pelzer A, Rosenau F, Wilhelm S (2010) Weapons of a pathogen: proteases and their role in virulence of Pseudomonas aeruginosa. In: Mendez-Vilas A (ed) Current research, technology and education topics in applied microbiology and microbial biotechnology, vol 2, pp 383–395
Horna G, Ruiz J (2021) Type 3 secretion system of Pseudomonas aeruginosa. Microbiol Res 246:126719
Hu X, Huang YY, Wang Y, Wang X, Hamblin MR (2018) Antimicrobial photodynamic therapy to control clinically relevant biofilm infections. Front Microbiol 9:1299
Hwang W, Yoon SS (2019) Virulence characteristics and an action mode of antibiotic resistance in multidrug-resistant Pseudomonas aeruginosa. Sci Rep 9(1):487
Jamal M, Andleeb S, Jalil F, Imran M, Nawaz MA, Hussain T, Ali M, Das CR (2017) Isolation and characterization of a bacteriophage and its utilization against multi-drug resistant Pseudomonas aeruginosa-2995. Life Sci 190:21–28
Jeong GJ, Khan F, Khan S, Tabassum N, Mehta S, Kim YM (2023) Pseudomonas aeruginosa virulence attenuation by inhibiting siderophore functions. Appl Microbiol Biotechnol 107(4):1019–1038
Jurado-Martín I, Sainz-Mejías M, McClean S (2021) Pseudomonas aeruginosa: an audacious pathogen with an adaptable arsenal of virulence factors. Int J Mol Sci 22(6):3128
Kapoor R, Wadman MW, Dohm MT, Czyzewski AM, Spormann AM, Barron AE (2011) Antimicrobial peptoids are effective against Pseudomonas aeruginosa biofilms. Antimicrob Agents Chemother 55(6):3054–3057
Karygianni L, Ren Z, Koo H, Thurnheer T (2020) Biofilm matrixome: extracellular components in structured microbial communities. Trends Microbiol 28(8):668–681
Khan F, Manivasagan P, Lee JW, Pham DTN, Oh J, Kim YM (2019) Fucoidan-stabilized gold nanoparticle-mediated biofilm inhibition, attenuation of virulence and motility properties in Pseudomonas aeruginosa PAO1. Mar Drugs 17(4):208
Kulasekara HD, Ventre I, Kulasekara BR, Lazdunski A, Filloux A, Lory S (2005) A novel two-component system controls the expression of Pseudomonas aeruginosa fimbrial cup genes. Mol Microbiol 55(2):368–380
Kwiatek M, Parasion S, Rutyna P, Mizak L, Gryko R, Niemcewicz M, Olender A, Łobocka M (2017) Isolation of bacteriophages and their application to control Pseudomonas aeruginosa in planktonic and biofilm models. Res Microbiol 168(3):194–207
Langendonk RF, Neill DR, Fothergill JL (2021) The building blocks of antimicrobial resistance in Pseudomonas aeruginosa: implications for current resistance-breaking therapies. Front Cell Infect Microbiol 11:665759
Lee EY, Choi DS, Kim KP, Gho YS (2008) Proteomics in gram-negative bacterial outer membrane vesicles. Mass Spectrom Rev 27(6):535–555
Li R, Yuan X, Wei J, Zhang X, Cheng G, Wang ZA, Du Y (2019) Synthesis and evaluation of a chitosan oligosaccharide-streptomycin conjugate against Pseudomonas aeruginosa biofilms. Mar Drugs 17(1):43
Liao C, Huang X, Wang Q, Yao D, Lu W (2022) Virulence factors of Pseudomonas aeruginosa and antivirulence strategies to combat its drug resistance. Front Cell Infect Microbiol 12:926758
Ma L, Conover M, Lu H, Parsek MR, Bayles K, Wozniak DJ (2009) Assembly and development of the Pseudomonas aeruginosa biofilm matrix. PLoS Pathog 5(3):e1000354
Ma L, Wang J, Wang S, Anderson EM, Lam JS, Parsek MR, Wozniak DJ (2012) Synthesis of multiple Pseudomonas aeruginosa biofilm matrix exopolysaccharides is post-transcriptionally regulated. Environ Microbiol 14(8):1995–2005
Malhotra S, Limoli DH, English AE, Parsek MR, Wozniak DJ (2018) Mixed communities of mucoid and nonmucoid Pseudomonas aeruginosa exhibit enhanced resistance to host antimicrobials. MBio 9(2)
Mikkelsen H, Sivaneson M, Filloux A (2011) Key two-component regulatory systems that control biofilm formation in Pseudomonas aeruginosa. Environ Microbiol 13(7):1666–1681
Mion S, Rémy B, Plener L, Brégeon F, Chabrière E, Daudé D (2019) Quorum quenching lactonase strengthens bacteriophage and antibiotic arsenal against Pseudomonas aeruginosa clinical isolates. Front Microbiol 10:2049
Mislin GL, Schalk IJ (2014) Siderophore-dependent iron uptake systems as gates for antibiotic Trojan horse strategies against Pseudomonas aeruginosa. Metallomics 6(3):408–420
Moradali MF, Ghods S, Rehm BHA (2017) Pseudomonas aeruginosa lifestyle: a paradigm for adaptation, survival, and persistence. Front Cell Infect Microbiol 7:39
Morris AJ, Jackson L, Yau YCW, Reichhardt C, Beaudoin T, Uwumarenogie S, Guttman KM, Lynne Howell P, Parsek MR, Hoffman LR, Nguyen D (2021) The role of Psl in the failure to eradicate Pseudomonas aeruginosa biofilms in children with cystic fibrosis. npj Biofilms Microbiomes 7(1):63
Mwangi J, Yin Y, Wang G, Yang M, Li Y, Zhang Z, Lai R (2019) The antimicrobial peptide ZY4 combats multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii infection. Proc Natl Acad Sci 116(52):26516–26522
Nadal Jimenez P, Koch G, Thompson JA, Xavier KB, Cool RH, Quax WJ (2012) The multiple signaling systems regulating virulence in Pseudomonas aeruginosa. Microbiol Mol Biol Rev 76(1):46–65
Orlandi VT, Rybtke M, Caruso E, Banfi S, Tolker-Nielsen T, Barbieri P (2014) Antimicrobial and anti-biofilm effect of a novel BODIPY photosensitizer against Pseudomonas aeruginosa PAO1. Biofouling 30(8):883–891
Pang Z, Raudonis R, Glick BR, Lin T-J, Cheng Z (2019) Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnol Adv 37(1):177–192
Passos da Silva D, Matwichuk ML, Townsend DO, Reichhardt C, Lamba D, Wozniak DJ, Parsek MR (2019) The Pseudomonas aeruginosa lectin LecB binds to the exopolysaccharide Psl and stabilizes the biofilm matrix. Nat Commun 10(1):2183
Pier GB (2007) Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity. Int J Med Microbiol 297(5):277–295
Reichhardt C, Parsek MR (2019) Confocal laser scanning microscopy for analysis of Pseudomonas aeruginosa biofilm architecture and matrix localization. Front Microbiol 10:677
Reynolds D, Kollef M (2021) The epidemiology and pathogenesis and treatment of Pseudomonas aeruginosa infections: an update. Drugs 81(18):2117–2131
Sakharkar MK, Jayaraman P, Soe WM, Chow VT, Sing LC, Sakharkar KR (2009) In vitro combinations of antibiotics and phytochemicals against Pseudomonas aeruginosa. J Microbiol Immunol Infect 42(5):364–370
Sharma G, Rao S, Bansal A, Dang S, Gupta S, Gabrani R (2014) Pseudomonas aeruginosa biofilm: potential therapeutic targets. Biologicals 42(1):1–7
Silva E, Teixeira JA, Pereira MO, Rocha CM, Sousa AM (2023) Evolving biofilm inhibition and eradication in clinical settings through plant-based antibiofilm agents. Phytomedicine 119:154973
Singh N, Paknikar KM, Rajwade J (2019) Gene expression is influenced due to ‘nano’ and ‘ionic’ copper in pre-formed Pseudomonas aeruginosa biofilms. Environ Res 175:367–375
Skariyachan S, Sridhar VS, Packirisamy S, Kumargowda ST, Challapilli SB (2018) Recent perspectives on the molecular basis of biofilm formation by Pseudomonas aeruginosa and approaches for treatment and biofilm dispersal. Folia Microbiol 63:413–432
Tetz GV, Artemenko NK, Tetz VV (2009) Effect of DNase and antibiotics on biofilm characteristics. Antimicrob Agents Chemother 53(3):1204–1209
Thi MTT, Wibowo D, Rehm BH (2020) Pseudomonas aeruginosa biofilms. Int J Mol Sci 21(22):8671
Tuon FF, Dantas LR, Suss PH, Tasca Ribeiro VS (2022) Pathogenesis of the Pseudomonas aeruginosa biofilm: a review. Pathogens 11(3):300
Vetrivel A, Ramasamy M, Vetrivel P, Natchimuthu S, Arunachalam S, Kim GS, Murugesan R (2021) Pseudomonas aeruginosa biofilm formation and its control. Biologics 1(3):312–336
Visca P, Imperi F, Lamont IL (2007) Pyoverdine siderophores: from biogenesis to biosignificance. Trends Microbiol 15(1):22–30
Wei Q, Ma LZ (2013) Biofilm matrix and its regulation in Pseudomonas aeruginosa. Int J Mol Sci 14(10):20983–21005
Wood SJ, Goldufsky JW, Seu MY, Dorafshar AH, Shafikhani SH (2023) Pseudomonas aeruginosa cytotoxins: mechanisms of cytotoxicity and impact on inflammatory responses. Cells 12(1):195
Yadav J, Kumari RM, Verma V, Nimesh S (2021) Recent development in therapeutic strategies targeting Pseudomonas aeruginosa biofilms—a review. Mater Today Proc 46:2359–2373
Zhang W, Sun J, Ding W, Lin J, Tian R, Lu L, Liu X, Shen X, Qian PY (2015) Extracellular matrix-associated proteins form an integral and dynamic system during Pseudomonas aeruginosa biofilm development. Front Cell Infect Microbiol 5:40
Zhao Y, Lu Z, Dai X, Wei X, Yu Y, Chen X, Zhang X, Li C (2018) Glycomimetic-conjugated photosensitizer for specific Pseudomonas aeruginosa recognition and targeted photodynamic therapy. Bioconjug Chem 29(9):3222–3230
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Mohan, M.S., Salim, S.A., Forgia, N., Busi, S. (2024). Pseudomonas aeruginosa Virulence Factors and Biofilm Components: Synthesis, Structure, Function and Inhibitors. In: Busi, S., Prasad, R. (eds) ESKAPE Pathogens. Springer, Singapore. https://doi.org/10.1007/978-981-99-8799-3_11
Download citation
DOI: https://doi.org/10.1007/978-981-99-8799-3_11
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-8798-6
Online ISBN: 978-981-99-8799-3
eBook Packages: MedicineMedicine (R0)